INTRODUCTION: Primary renal Ewing sarcoma/PNET is an uncommon and very aggressive tumor. PRESENTATION OF CASE: : We report the case of a young woman who underwent nephrectomy for a renal mass from unknown etiology. Histologic analysis found small tumoral cells in rosette formation, and immunohistochemical staining was positive for CD99, and focally positive for vimentin and Protein S-100. A post operative abdominal computed tomography (CT) scan revealed a residual renal processus with hepatic wounds and abdominal metastatic nodes. After 6 cycles of chemotherapy including Vincristine, Doxorubicin, Cyclophosphamide, the response was considered as good. DISCUSSION: Ewing's sarcoma/PNET of kidney is a member of the family of small round cell tumors and it should be differentiated from Wilms tumor, neuroblastoma, rhabdomyosarcoma and lymphoblastic lymphoma. The principle management of its treatment have been extrapolated from the treatment of osseous Ewing sarcoma of bone. CONCLUSION: Despite aggressive treatment, primary renal Ewing sarcoma/PNET has a poor prognosis. It requires a multidisciplinary approach including oncologists, urologists and radiation oncologists.
INTRODUCTION:Primary renal Ewing sarcoma/PNET is an uncommon and very aggressive tumor. PRESENTATION OF CASE: : We report the case of a young woman who underwent nephrectomy for a renal mass from unknown etiology. Histologic analysis found small tumoral cells in rosette formation, and immunohistochemical staining was positive for CD99, and focally positive for vimentin and Protein S-100. A post operative abdominal computed tomography (CT) scan revealed a residual renal processus with hepatic wounds and abdominal metastatic nodes. After 6 cycles of chemotherapy including Vincristine, Doxorubicin, Cyclophosphamide, the response was considered as good. DISCUSSION: Ewing's sarcoma/PNET of kidney is a member of the family of small round cell tumors and it should be differentiated from Wilms tumor, neuroblastoma, rhabdomyosarcoma and lymphoblastic lymphoma. The principle management of its treatment have been extrapolated from the treatment of osseous Ewing sarcoma of bone. CONCLUSION: Despite aggressive treatment, primary renal Ewing sarcoma/PNET has a poor prognosis. It requires a multidisciplinary approach including oncologists, urologists and radiation oncologists.
Authors: Mark Bernstein; Heinrich Kovar; Michael Paulussen; R Lor Randall; Andreas Schuck; Lisa A Teot; Herbert Juergens Journal: Oncologist Date: 2006-05
Authors: Yuvaraja B Thyavihally; Hemant B Tongaonkar; Sudeep Gupta; Purna A Kurkure; Pratibha Amare; Mary Ann Muckaden; Sangita B Desai Journal: Urology Date: 2008-02 Impact factor: 2.649
Authors: Andrea Hunold; Nicole Weddeling; Michael Paulussen; Andreas Ranft; Caren Liebscher; Herbert Jürgens Journal: Pediatr Blood Cancer Date: 2006-11 Impact factor: 3.167
Authors: Christine Juergens; Claire Weston; Ian Lewis; Jeremy Whelan; Michael Paulussen; Odile Oberlin; Jean Michon; Andreas Zoubek; Herbert Juergens; Alan Craft Journal: Pediatr Blood Cancer Date: 2006-07 Impact factor: 3.167
Authors: Nicolaus Friedrichs; Roland Vorreuther; Christopher Poremba; Karl-Ludwig Schafer; Alfred Böcking; Reinhard Buettner; Hui Zhou Journal: Pathol Res Pract Date: 2002 Impact factor: 3.250
Authors: Patrick Van Winkle; Anne Angiolillo; Mark Krailo; Ying-Kuen Cheung; Barry Anderson; Virginia Davenport; Gregory Reaman; Mitchell S Cairo Journal: Pediatr Blood Cancer Date: 2005-04 Impact factor: 3.167
Authors: Holcombe E Grier; Mark D Krailo; Nancy J Tarbell; Michael P Link; Christopher J H Fryer; Douglas J Pritchard; Mark C Gebhardt; Paul S Dickman; Elizabeth J Perlman; Paul A Meyers; Sarah S Donaldson; Sheila Moore; Aaron R Rausen; Teresa J Vietti; James S Miser Journal: N Engl J Med Date: 2003-02-20 Impact factor: 91.245
Authors: J Zucman; O Delattre; C Desmaze; B Plougastel; I Joubert; T Melot; M Peter; P De Jong; G Rouleau; A Aurias Journal: Genes Chromosomes Cancer Date: 1992-11 Impact factor: 5.006